High-on Clopidogrel Platelet Reactivity as Assessed by Thromboelastography in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
- Conditions
- I21I25I26Acute myocardial infarctionChronic ischaemic heart diseasePulmonary embolism
- Registration Number
- DRKS00024509
- Lead Sponsor
- Kardiologie und Angiologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 172
Inclusion Criteria
- Informed consent
- Age of =18
- Atrial fibrillation/flutter with an indication for permanent anticoagulation therapy (i.e. CHA2DS2VASC =1 for man and CHA2DS2VASC =2 for women)
- Percutaneous coronary intervention in the previous 3 days
Exclusion Criteria
- Contraindication for Clopidogrel intake
- History of stent-thrombosis
- Patient not suitable for inclusion in the study
(e.g. incompliance, drug abuse, unwillingness to adhere to the protocol)
- GPIIb/IIIa inhibition within the last 24h
- Use of Prasugrel or Ticagrelor within the last 7 days
- Less than 50 thousand platelets per µl blood
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method